Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2022
Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1Kohei Doi, Koichi Murata, Shuji Ito, et al.
Rheumatology (Oxford, England)|November 10, 2025
Baseline neutrophil-to-lymphocyte ratio predicts drug retention of IL-6 inhibitors and JAK inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuhei Fujisawa, Ryu Watanabe, Tadashi Okano, et al.
Rheumatology (Oxford, England)|October 29, 2025
Clinical Efficacy of JAK Inhibitors for Rheumatoid Arthritis Patients with Poor-Prognosis Factors: The ANSWER Cohort StudyYuji Nozaki, Koichi Murata, Akira Onishi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 17, 2019
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive DermatomyositisHideaki Tsuji, Ran Nakashima, Yuji Hosono, et al.
Modern Rheumatology|March 21, 2024
Consensus statement on the management of late-onset rheumatoid arthritisMasayo Kojima, Takahiko Sugihara, Yutaka Kawahito, et al.
Joint Bone Spine|May 27, 2026
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
Lupus|June 14, 2021
Correlation between irreversible organ damage and the quality of life of patients with systemic lupus erythematosus: The Kyoto Lupus Cohort surveyYudai Takase, Takeshi Iwasaki, Hiroshi Doi, et al.
Rheumatology (Oxford, England)|March 10, 2026
Renal outcomes in ANCA-associated vasculitis without clinically apparent kidney involvement: a multicentre REVEAL cohort studyTomoki Taniguchi, Ryosuke Hiwa, Shingo Iwasaka, et al.
Rheumatology (Oxford, England)|October 30, 2024
Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritisNozomi Nishimura, Akira Onishi, Wataru Yamamoto, et al.
Rheumatology (Oxford, England)|February 6, 2024
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Shuhei Hattori, et al.
Pageof 23